Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam
- 1 September 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 380 (2-3) , 67-72
- https://doi.org/10.1016/s0014-2999(99)00541-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugsEuropean Journal of Pharmacology, 1998
- Pharmacology of glutamate receptor antagonists in the kindling model of epilepsyProgress in Neurobiology, 1998
- Interaction of Calcium Channel Blockers and Excitatory Amino Acid Antagonists with Conventional Antiepileptic DrugsCNS Drug Reviews, 1996
- Interactions of excitatory amino acid antagonists with conventional antiepileptic drugsMetabolic Brain Disease, 1996
- The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepilepticsEuropean Journal of Pharmacology, 1995
- Effects of the non‐NMDA antagonists NBQX and the 2,3‐benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenilBritish Journal of Pharmacology, 1994
- The effect of the non-NMDA receptor antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonist d-CPPene on the development of amygdala kindling and on amygdala-kindled seizuresEpilepsy Research, 1994
- Mechanisms of Action of Anticonvulsant DrugsEpilepsia, 1988
- Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerationsEpilepsy Research, 1988
- A permanent change in brain function resulting from daily electrical stimulationExperimental Neurology, 1969